https://doi.org/10.4081/hls.2024.13044
Prevention of contaminated aerosol and the transmission during nebulized therapy in hospital settings: a systematic review
Published: 9 September 2024
Abstract Views: 169
PDF: 75
Supplementary Materials: 2
HTML: 0
Supplementary Materials: 2
HTML: 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Inhalation nebulization therapy is important for administering medications to patients in aerosolized form. However, there are persistent apprehensions in healthcare settings regarding aerosol contamination because of the significant infection risk. Despite rigorous adherence to established hospital protocols, concerns about potential contamination and transmission persist, raising considerable apprehension about nosocomial pneumonia. This condition shows the urgent need for implementing highly effective strategies to ensure patient safety during nebulization therapy. Therefore, this study aimed to review current investigations, focusing on interventions to mitigate aerosol contamination and minimize the transmission of contaminated aerosols. Adhering to the Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) guidelines, this systematic review included an exhaustive analysis of randomized and non-randomized clinical trials as well as, simulated experimental and in vitro studies published in English in the past decade. A meticulous search was conducted across four major databases, namely ScienceDirect, Cumulative Index to Nursing & Allied Health (CINAHL), PubMed, and Scopus. A total of 37 pertinent studies were identified and subjected to rigorous analysis. The preventive measures include a range of strategies, such as the use of masks by therapists, thorough disinfection of nebulizers, integration of filters, and regular environmental cleaning in the vicinity of the patient. In conclusion, these multifaceted interventions are significant in preventing the administration of contaminated aerosols and curbing the proliferation of infectious agents in the hospital environment.
mccarthy sd, gonzález he, higgins bd. future trends in nebulized therapies for pulmonary disease. J Pers Med 2020;10:37.
Barjaktarevic IZ, Milstone AP. Nebulized Therapies in COPD: Past, Present, and the Future. Int J Chron Obstruct Pulmon Dis 2020;15:1665–77.
Matuszak M, Ochowiak M, Włodarczak S, et al. State-of-the-art review of the application and development of various methods of aerosol therapy. Int J Pharm 2022;614:121432.
Harris JC, Collins MS, Huang PH, et al. Bacterial surface detachment during nebulization with contaminated reusable home nebulizers. Brissette CA, editor. Microbiol Spectr 2022;10(1).
Reychler G, Vecellio L, Dubus JC. Nebulization: A potential source of SARS-CoV-2 transmission. Respir Med Res 2020;78:100778.
Swanson CS, Dhand R, Cao L, et al. Microbiome-based source identification of microbial contamination in nebulizers used by inpatients. J Hospital Infection 2022;122:157–61.
Elmashae Y, Yermakov M, Frank E, et al. Exposure of home-attending healthcare workers to aerosolized medications (simulation study). J Aerosol Sci 2019;133:49–55.
Kao CL, Lin CH. A novel mask to prevent aerosol spread during nebulization treatment. J Formosan Med Assoc 2021;120:769–71.
Swanson CS, Dhand R, Cao L, et al. Microbiome-scale analysis of aerosol facemask contamination during nebulization therapy in the hospital. J Hospital Infect 2023;101890.
O’Malley CA. Device cleaning and infection control in aerosol therapy. Respir Care 2015;60:917–30.
Bell J, Alexander L, Carson J, et al. Nebulizer hygiene in cystic fibrosis: evidence-based recommendations. Breathe 2020;16:190328.
Burnett E. Effective infection prevention and control: the nurse’s role. Nursing Standard 2018;33:68–72.
Russell CD, Koch O, Laurenson IF, et al. Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study. J Hospital Infect 2016;92:273–9.
Aiesh BM, Qashou R, Shemmessian G, et al. Nosocomial infections in the surgical intensive care unit: an observational retrospective study from a large tertiary hospital in Palestine. BMC Infect Dis 2023;23:686.
Kim BG, Kang M, Lim J, et al. Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia. BMC Pulm Med 2022;22:21.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;n71.
Schiavenato M, Chu F. PICO: What it is and what it is not. Nurse Educ Pract 2021;56:103194.
MacIntyre CR, Wang Q, Rahman B, et al. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev Med (Baltim) 2014;62:1–7.
Asadi S, Cappa CD, Barreda S, et al. Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities. Sci Rep 2020;10:15665.
Sterr CM, Nickel IL, Stranzinger C, et al. Medical face masks offer self-protection against aerosols: An evaluation using a practical in vitro approach on a dummy head. PLoS One 2021;16:e0248099.
Armand Q, Whyte HE, Verhoeven P, et al. Impact of medical face mask wear on bacterial filtration efficiency and breathability. Environ Technol Innov 2022;28:102897.
Liu J, Hao M, Chen S, et al. Numerical evaluation of face masks for prevention of COVID-19 airborne transmission. Environ Sci Pollut Res 2022;29:44939–53.
Weng CH, Kao CL, Chiu PW, et al. A full-face mask for protection against respiratory infections. Biomed Eng Online 2022;21:62.
Han Z, Wang L, Liu Y, et al. How do three-layer surgical masks prevent SARS-CoV-2 aerosol transmission? Sep Purif Technol 2023;314:123574.
Towle D, Callan DA, Farrel PA, et al. Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens. J Cystic Fibrosis 2013;12:512–6.
Towle D, Callan DA, Lamprea C, Murray TS. Baby bottle steam sterilizers for disinfecting home nebulizers inoculated with non-tuberculous mycobacteria. J Hospital Infect 2016;92:222–5.
Moore J, Millar B. Susceptibility of the Mycobacterium abscessus complex to drying: Implications for nebulizer hygiene in patients with cystic fibrosis. Int J Mycobacteriol 2020;9:173–5.
Lopes MS, Ferreira JRF, da Silva KB, et al. Disinfection of corrugated tubing by ozone and ultrasound in mechanically ventilated tracheostomized patients. J Hospital Infect 2015;90:304–9.
Moore JE, Moore RE, Bell J, Millar BC. Importance of nebulizer drying for patients with cystic fibrosis. Respir Care 2020;65:1444–50.
Hohenwarter K, Prammer W, Aichinger W, Reychler G. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers. J Cystic Fibrosis 2016;15:78–84.
Moore JE, Millar BC. Susceptibility of Staphylococcus aureus (MSSA and MRSA) to drying: implications for nebulizer hygiene in patients with cystic fibrosis. J Hospital Infect 2020;105:366–7.
da Costa Luciano C, Olson N, Tipple AFV, Alfa M. Evaluation of the ability of different detergents and disinfectants to remove and kill organisms in traditional biofilm. Am J Infect Control 2016;44:e243–9.
Rodney J, Ojano‐Dirain CP, Antonelli PJ, Silva RC. Effect of repeated tracheostomy tube reprocessing on biofilm formation. Laryngoscope 2016;126:996–9.
Towle D, Baker V, Schramm C, et al. Ozone disinfection of home nebulizers effectively kills common cystic fibrosis bacterial pathogens. Pediatr Pulmonol 2018;53:599–604.
Moore J, Millar B. Effect of Ultraviolet-c (UVc) light and ozone on the survival of Mycobacterium abscessus complex organisms associated with cystic fibrosis. Int J Mycobacteriol 2022;11:256.
Ibáñez-Cervantes G, Cruz-Cruz C, Durán-Manuel EM, et al. Disinfection efficacy of ozone on ESKAPE bacteria biofilms: Potential use in difficult-to-access medical devices. Am J Infect Control 2023;51:11–7.
Pineau L, Radix C, Weber DJ. Comparison of the sporicidal activity of a UV disinfection process with three FDA-cleared sterilants. Am J Infect Control 2022;50:1316–21.
Hu HC, Liu HC, Chen YH, et al. The impact of aerosolized mucolytic agents on the airflow resistance of bacterial filters used in mechanical ventilation. J Formosan Med Assoc 2015;114:717–21.
Mac Giolla Eain M, Cahill R, MacLoughlin R, Nolan K. Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control. Drug Deliv 2022;29:10–7.
Sugget JA, Nagel M. Efficiency of a nebulizer filter kit to prevent environmental contamination during nebulizer therapy. Chest 2022;162:A2472.
Phu HT, Park Y, Andrews AJ, et al. Design and evaluation of a portable negative pressure hood with HEPA filtration to protect healthcare workers treating patients with transmissible respiratory infections. Am J Infect Control 2020;48:1237–43.
Franke G, Knobling B, Brill FH, et al. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2. J Hospital Infect 2021;112:108–13.
Trinh VM, Yuan MH, Chen YH, et al. Chlorine dioxide gas generation using a rotating packed bed for air disinfection in a hospital. J Clean Prod 2021;320:128885.
Xia T, Guo K, Pan Y, et al. Temporal and spatial far-ultraviolet disinfection of exhaled bioaerosols in a mechanically ventilated space. J Hazard Mater 2022;436:129241.
Nunayon SS, Wang M, Zhang HH, Lai ACK. Evaluating the efficacy of a rotating upper-room UVC-LED irradiation device in inactivating aerosolized Escherichia coli under different disinfection ranges, air mixing, and irradiation conditions. J Hazard Mater 2022;440:129791.
Wang MH, Zhang HH, Chan CK, et al. Experimental study of the disinfection performance of a 222-nm Far-UVC upper-room system on airborne microorganisms in a full-scale chamber. Build Environ 2023;236:110260.
Lu YH, Wu H, Zhang HH, et al. Synergistic disinfection of aerosolized bacteria and bacteriophage by far-UVC (222-nm) and negative air ions. J Hazard Mater 2023;441:129876.
Sottani C, Favorido Barraza G, Frigerio F, et al. Effectiveness of a combined UV-C and ozone treatment in reducing healthcare-associated infections in hospital facilities. J Hospital Infect 2023;139:207–16.
Swarnakar R, Gupta N, Halder I, Khilnani G. Guidance for nebulization during the COVID-19 pandemic. Lung India 2021;38:86.
Zhang M, Zheng H, Wang J. Strategy of using personal protective equipment during aerosol-generating medical procedures with COVID-19. J Clin Anesth 2020;66:109911.
Driessche K Vanden, Hens N, Tilley P, et al. Surgical masks reduce airborne spread of pseudomonas aeruginosa in colonized patients with cystic fibrosis. Am J Respir Crit Care Med 2015;192:897–9.
Martinelli L, Kopilaš V, Vidmar M, et al. Face masks during the COVID-19 pandemic: a simple protection tool with many meanings. Front Public Health 2021;8:606635.
Katiyar SK, Gaur SN, Solanki RN, et al. Indian guidelines on nebulization therapy. Indian J Tuberc 2022;69:S1–191.
Central for Disease Control and Prevention (CDC). Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1–36.
CDC. Ventilator-associated Pneumonia (VAP). 2023 [cited 2023 Aug 12]. Ventilator-associated Pneumonia Basics. Available from: https://www.cdc.gov/ventilator-associated-pneumonia/about/index.html.
Collins MS, O’Brien M, Schramm CM, Murray TS. Repeated hot water and steam disinfection of Pari LC Plus® nebulizers alter nebulizer output. J Cystic Fibrosis 2019;18:233–5.
Manor E, Gur M, Geffen Y, Bentur L. Cleaning and infection control of airway clearance devices used by CF patients. Chron Respir Dis 2017;14:370–6.
Caskey S, Moore JE, Rendall JC. In vitro activity of seven hospital biocides against Mycobacterium abscessus: Implications for patients with cystic fibrosis. Int J Mycobacteriol 2018;7:45–7.
Collins MS, Harris J, Murray T. Efficacy of thermal and chemical methods of nebulizer disinfection of CF pathogens. In: Cystic fibrosis. European Respiratory Society; 2019. p. PA981.
Hutauruk SM, Hermani B, Monasari P. Role of chlorhexidine on tracheostomy cannula decontamination in relation to the growth of Biofilm-Forming Bacteria Colony- a randomized controlled trial study. Ann Med Surg 2021;67:102491.
Epelle EI, Macfarlane A, Cusack M, Burns A, Thissera B, Mackay W, et al. Bacterial and fungal disinfection via ozonation in air. J Microbiol Methods 2022;194:106431.
Cristiano L. Could ozone be an effective disinfection measure against the novel coronavirus (SARS-CoV-2)? J Prev Med Hyg 2020;61:E301.
Khan M, McDonald M, Mundada K, Willcox M. Efficacy of ultraviolet radiations against coronavirus, bacteria, fungi, fungal spores and biofilm. Hygiene 2022;2:120–31.
Van Heerden L, Van Aswegen H, Van Vuuren S, et al. Contamination of nebulizers and surrounding air at the bedside of mechanically ventilated patients. Southern Afr J Crit Care 2017;33:23–7.
Liu Z, Xiao X, Jiang C, et al. Assessment of the air disinfection effect of low-concentration ozone in a closed environment. Build Environ 2023;244:110747.
Alebrahim MA, Bakkar MM, Al Darayseh A, et al. Awareness and knowledge of the effect of Ultraviolet (UV) radiation on the eyes and the relevant protective practices: a cross-sectional study from Jordan. Healthcare 2022;10:2414.
Grignani E, Mansi A, Cabella R, et al. Safe and effective use of ozone as air and surface disinfectant in the conjuncture of Covid-19. Gases 2020;1:19–32.
Adanur S, Jayswal A. Filtration mechanisms and manufacturing methods of face masks: An overview. J Industrial Textiles 2022;51:3683S-3717S.
Rennert-May E, Conly J, Leal J, et al. Economic evaluations and their use in infection prevention and control: a narrative review. Antimicrob Resist Infect Control 2018;7:31.
How to Cite
Ariningpraja, R. T., Widyawati, I. Y., & Azizah, N. (2024). Prevention of contaminated aerosol and the transmission during nebulized therapy in hospital settings: a systematic review. Healthcare in Low-Resource Settings, 12(s1). https://doi.org/10.4081/hls.2024.13044
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.